Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 02, 2023

BUY
$5.04 - $8.6 $26,712 - $45,580
5,300 New
5,300 $27,000
Q3 2021

Oct 22, 2021

BUY
$11.73 - $16.08 $62,169 - $85,223
5,300 New
5,300 $69,000
Q3 2020

Dec 14, 2020

SELL
$11.59 - $14.93 $84,607 - $108,989
-7,300 Closed
0 $0
Q2 2020

Jul 23, 2020

SELL
$11.79 - $15.97 $228,725 - $309,818
-19,400 Reduced 72.66%
7,300 $91,000
Q2 2019

Jul 25, 2019

BUY
$17.38 - $26.88 $269,390 - $416,640
15,500 Added 138.39%
26,700 $717,000
Q1 2019

Apr 19, 2019

BUY
$9.2 - $21.21 $92,920 - $214,221
10,100 Added 918.18%
11,200 $192,000
Q3 2018

Oct 19, 2018

BUY
$8.1 - $13.6 $8,910 - $14,960
1,100 New
1,100 $14,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.